Article
Effect of CYP1A2 polymorphism on the pharmacokinetics of agomelatine in Chinese healthy male volunteers.
Journal of clinical pharmacy and therapeutics - 1 Apr 2014
Song L, Du Q, Jiang X, Wang L
Abstract excerpt
WHAT IS KNOWN AND OBJECTIVE: Agomelatine is a melatonin (MT) analogue with agonistic properties and has been proven to be effective for various types of depressive symptoms. Following oral administration, agomelatine is primarily metabolized by the hepatic cytochrome P450 isoenzyme CYP1A2. The purpose of this study was to assess the influence of CYP1A2 single nucleotide polymorphisms (SNPs, rs762551, rs2069514,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
